MedTrace Logo

DXR Stent for Vascular Healing and Thrombus Formation: OCT Study

NCT02932995 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2016-10-19

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy of a novel dual drug-eluting stent (DXR stent), which slowly releases both cilostazol and paclitaxel, for strut coverage, malapposition, and thrombus formation, assessed by an optical coherence tomography.

Conditions

Sponsors & Collaborators

  • Konyang University Hospital

    collaborator OTHER

  • Kyunghee University Medical Center

    collaborator OTHER

  • Korea University Guro Hospital

    collaborator OTHER

  • Ulsan University Hospital

    collaborator OTHER

  • Jeju National University Hospital

    collaborator OTHER

  • Chung-Ang University

    lead OTHER

Principal Investigators

  • Sang-Wook Kim, MD, PhD · Chung-Ang University Hosptial, Chung-Ang University College of Medicine

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2017-10-31
Completion
2020-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02932995 on ClinicalTrials.gov